Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Aug 16;228(4):391-401.
doi: 10.1093/infdis/jiad034.

Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks

Affiliations
Meta-Analysis

Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks

Pengfei Li et al. J Infect Dis. .

Abstract

Background: This study aims to comparatively analyze clinical features, treatment, and patient outcomes between the previous and the 2022 mpox (monkeypox) outbreaks.

Methods: Five bibliographic databases were searched for studies reporting clinical features, management, and patient outcomes of mpox. Systematic review and meta-analysis were performed.

Results: In total, 73 studies were included in the systematic review, of which 33 studies were subjected to meta-analysis. Previous outbreaks substantially affected children, whereas the 2022 outbreak primarily affected male adults, of which 94.66% (95% confidence interval [CI], 88.03-98.95) were men who have sex with men. Furthermore, 72.47% (95% CI, 51.04-89.71) reported high-risk sexual activity and the overall human immunodeficiency virus (HIV) prevalence was 37.65% (95% CI, 30.09-45.50). Skin lesions remain the typical symptom; however, their anatomic distribution differed. Systemic manifestations were common, but rectal pain was unique to the 2022 outbreak. The estimated overall fatality during past outbreaks in Africa was 4.61% (95% CI, 2.39%-7.35%), whereas 6.34% (95% CI, 3.35%-10.10%) of patients from the 2022 outbreak required hospitalization. Antiviral treatment, in particular tecovirimat, has been prescribed for a subset of patients, but the efficacy remains inconclusive.

Conclusions: These findings are important for better understanding the disease and guiding adequate response to mpox outbreaks.

Keywords: mpox; outcomes; sexual activity; symptoms; treatment.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest . All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Study selection.
Figure 2.
Figure 2.
The incidence rate of MSM in 18 studies included in the analysis. Abbreviations: CI, confidence interval; MSM, men who have sex with men.Complete reference information for the following references Duque et al (2022), Minhaj et al (2022), Miura et al (2022), Patel et al (2022), Peiro-Mestres et al (2022), Martinez et al (2022), Mailhe et al (2022), Caria et al (2022), Cassir et al (2022), Garcia-Piqueras et al (2022), Gaspari et al (2022), Hoffmann et al (2022), Nouchi et al (2022), Nunez et al (2022), Sheffer et al (2022), Caldeira et al (2022) cited in Figure 2 are listed in the Supplementary Material.
Figure 3.
Figure 3.
The incidence rate of (A) high-risk sexual activities (condomless/multipartner sexual activity; 5 studies included) and (B) human immunodeficiency virus (HIV) positivity rate (15 studies included) in patients of the 2022 mpox outbreak.Complete reference information for the following references Duque et al (2022), Patel et al (2022), Peiro-Mestres et al (2022), Martinez et al (2022), Mailhe et al (2022), Caria et al (2022), Cassir et al (2022), Garcia-Piqueras et al (2022), Gaspari et al (2022), Hoffmann et al (2022), Nouchi et al (2022), Nunez et al (2022), and Sheffer et al (2022) cited in Figure 3 are listed in the Supplementary Material.
Figure 4.
Figure 4.
Comparison of clinical symptoms of patients between (A) the previous (9 studies included) and (B) the 2022 (16 studies included) mpox outbreaks.
Figure 5.
Figure 5.
Distribution of skin lesions in patients of the previous and the 2022 outbreaks. A, The distribution of skin lesions in patients from the previous outbreaks (5 studies included). B, The distribution of skin lesions in patients from the 2022 outbreaks (14 studies included).
Figure 6.
Figure 6.
Clinical outcomes in patients during the previous and the 2022 outbreaks. A, The fatality rate of patients from major endemic African countries in previous mpox outbreaks (10 studies included). B, The rate of hospitalization in the current outbreak (9 studies included).Complete reference information for the following references Pittman et al (2022), Mukinda et al (1997), Hutin et al (2001), Kalthan et al (2018), Akar et al (2020), Formenty et al (2010), Nakoune et al (2017), Doshi et al (2019), Yinka-Ogunleye et al (2019), Besombes et al (2022), Duque et al (2022), Patel et al (2022), Mailhe et al (2022), Caria et al (2022), Garcia-Piqueras et al (2022), Hoffmann et al (2022), Nunez et al (2022) cited in Figure 6 are listed in the Supplementary Material.

References

    1. Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis 2005; 41:1765–71. - PubMed
    1. Mauldin MR, McCollum AM, Nakazawa YJ, et al. . Exportation of monkeypox virus from the African continent. J Infect Dis 2022; 225:1367–76. - PMC - PubMed
    1. Centers for Disease Control and Prevention . Past U.S. cases and outbreaks. https://www.cdc.gov/poxvirus/monkeypox/outbreak/us-outbreaks.html#:∼:tex.... Accessed 17 February 2023.
    1. Reed KD, Melski JW, Graham MB, et al. . The detection of monkeypox in humans in the Western hemisphere. N Engl J Med 2004; 350:342–50. - PubMed
    1. Bunge EM, Hoet B, Chen L, et al. . The changing epidemiology of human monkeypox—a potential threat? A systematic review. PLoS Negl Trop Dis 2022; 16:e0010141. - PMC - PubMed

Publication types

Substances